Literature DB >> 11837841

Risk factors for survival and local control in chondrosarcoma of bone.

F Fiorenza1, A Abudu, R J Grimer, S R Carter, R M Tillman, K Ayoub, D C Mangham, A M Davies.   

Abstract

We studied 153 patients with non-metastatic chondrosarcoma of bone to determine the risk factors for survival and local tumour control. The minimum follow-up was for five years; 52 patients had axial and 101 appendicular tumours. Surgical treatment was by amputation in 27 and limb-preserving surgery in 126. The cumulative rate of survival of all patients, at 10 and 15 years, was 70% and 63%, respectively; 40 patients developed a local recurrence between 3 and 87 months after surgery and 49 developed metastases. Local recurrence was associated with poor survival in patients with concomitant metastases but not in those without. On multivariate analysis independent risk factors for rates of survival include extracompartmental spread, development of local recurrence and high histological grade. Independent risk factors for local recurrence include inadequate surgical margins and tumour size greater than 10 cm. Location within the body, the type of surgery and the duration of symptoms are of no prognostic significance. Surgical excision with an oncologically wide margin provides the best prospect both for cure and local control in these patients.

Entities:  

Mesh:

Year:  2002        PMID: 11837841     DOI: 10.1302/0301-620x.84b1.11942

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  89 in total

1.  Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients.

Authors:  Suzan H M Verdegaal; Judith V M G Bovée; Twinkal C Pansuriya; Robert J Grimer; Harzem Ozger; Paul C Jutte; Mikel San Julian; David J Biau; Ingrid C M van der Geest; Andreas Leithner; Arne Streitbürger; Frank M Klenke; Francois G Gouin; Domenico A Campanacci; Perrine Marec-Berard; Pancras C W Hogendoorn; Ronald Brand; Antonie H M Taminiau
Journal:  Oncologist       Date:  2011-12-06

Review 2.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn; Jay S Wunder; Benjamin A Alman
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

3.  Low-grade chondrosarcoma of bone: experiences from the Vienna Bone and Soft Tissue Tumour Registry.

Authors:  Philipp T Funovics; Joannis Panotopoulos; Manuel Sabeti-Aschraf; Farshid Abdolvahab; Josef M Funovics; Susanna Lang; Rainer I Kotz; Martin Dominkus
Journal:  Int Orthop       Date:  2010-08-28       Impact factor: 3.075

4.  Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78.

Authors:  Arne Streitbuerger; Marcel Henrichs; Helmut Ahrens; Claudia Lanvers-Kaminzky; Francois Gouin; Georg Gosheger; Jendrik Hardes
Journal:  Int Orthop       Date:  2010-10-02       Impact factor: 3.075

5.  Chondrosarcoma of bone: lessons from 46 operated cases in a single institution.

Authors:  Olavo Pires de Camargo; André Mathias Baptista; Marcelo Junqueira Atanásio; Daniel Reis Waisberg
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

6.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

Review 7.  The clinical management of chondrosarcoma.

Authors:  Richard F Riedel; Nicole Larrier; Leslie Dodd; David Kirsch; Salutario Martinez; Brian E Brigman
Journal:  Curr Treat Options Oncol       Date:  2009-02-24

8.  Extended intralesional treatment versus resection of low-grade chondrosarcomas.

Authors:  Chad Aarons; Benjamin K Potter; Sheila C Adams; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

9.  Grade I chondrosarcoma of bone: the Münster experience.

Authors:  Arne Streitbürger; Helmut Ahrens; Maurice Balke; Horst Buerger; Winfried Winkelmann; Georg Gosheger; Jendrik Hardes
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

10.  Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma.

Authors:  Hidetatsu Outani; Kenichiro Hamada; Yoshinori Imura; Kazuya Oshima; Tsukasa Sotobori; Yusuke Demizu; Shigeki Kakunaga; Susumu Joyama; Reiko Imai; Tomoaki Okimoto; Norifumi Naka; Ikuo Kudawara; Takafumi Ueda; Nobuhito Araki; Tadashi Kamada; Hideki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.